Skip to main content
SpringerLink
Log in

IBD

Intravenous iron in IBD—what's the best preparation?

  • News & Views
  • Published:

From Nature Reviews Gastroenterology & Hepatology

View current issue Sign up to alerts

Iron deficiency anemia can occur secondary to IBD. A new clinical trial demonstrates that ferric carboxymaltose is more cost-effective, convenient and efficacious than iron sucrose for treating iron deficiency anemia in patients with IBD, an innovation that could make anemia treatment easier for clinicians, patients and health-care providers alike.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Rouault, T. Pathogenic bacteria prefer heme. Science 305, 1577–1578 (2004).

    Article  CAS  Google Scholar 

  2. Kell, D. B. Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. BMC Med. Genomics 2, 2 (2009).

    Article  Google Scholar 

  3. Ganz, T. Hepcidin and iron regulation: ten years later. Blood 117, 4425–4433 (2011).

    Article  CAS  Google Scholar 

  4. Clark, S. F. Iron deficiency anemia. Nutr. Clin. Pract. 34, 699–718 (2008).

    Google Scholar 

  5. Stein, J., Hartmann, F. & Dignass, A. U. Diagnosis and management of iron deficiency anemia in patients with IBD. Nat. Rev. Gastroenterol. Hepatol. 7, 599–610 (2010).

    Article  CAS  Google Scholar 

  6. Evstatiev, R. et al. FERGIcor, a randomized controlled trial for iron deficiency anemia in inflammatory bowel disease. Gastroenterology http://dx.doi.org/10.1053/j.gastro.2011.06.005.

  7. Ross, D. N. Oral and intravenous iron therapy in the anaemia of rheumatoid arthritis. Ann. Rheum. Dis. 9, 358–362 (1950).

    Article  CAS  Google Scholar 

  8. Goodhand, J. R. et al. Prevalence and management of anemia in children, adolescents, and adults with inflammatory bowel disease. Inflamm. Bowel Dis. http://dx.doi.org/10.1002/ibd.21740.

  9. Auerbach, M. & Ballard, H. Clinical use of intravenous iron: administration, efficacy and safety. Hematology Am. Soc. Hematol. Educ. Program. 338–347 (2010).

  10. Porter, M. E. What is value in health care? N. Engl. J. Med. 363, 2477–2481 (2010).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Servicio de Aparato Digestivo, Hospital Clínico Universitario Lozano Blesa, CIBEREHD, Avenida San Juan Bosco 15, Zaragoza, 50009, Spain

    Fernando Gomollón

  2. Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, CIBEREHD, Calle de Diego de León 62, Madrid, 28006, Spain

    Javier P. Gisbert

Authors
  1. Fernando Gomollón
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Javier P. Gisbert
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fernando Gomollón.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gomollón, F., Gisbert, J. Intravenous iron in IBD—what's the best preparation?. Nat Rev Gastroenterol Hepatol 8, 477–478 (2011). https://doi.org/10.1038/nrgastro.2011.132

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrgastro.2011.132

  • Springer Nature Limited

Search

Navigation